Mega Genomics 대차 대조표 상태
재무 상태 기준 확인 5/6
Mega Genomics has a total shareholder equity of CN¥662.6M and total debt of CN¥21.7M, which brings its debt-to-equity ratio to 3.3%. Its total assets and total liabilities are CN¥832.1M and CN¥169.4M respectively. Mega Genomics's EBIT is CN¥32.0M making its interest coverage ratio -8.2. It has cash and short-term investments of CN¥508.9M.
주요 정보
3.3%
부채 비율
CN¥21.69m
부채
| 이자 보상 비율 | -8.2x |
| 현금 | CN¥508.93m |
| 주식 | CN¥662.64m |
| 총 부채 | CN¥169.43m |
| 총 자산 | CN¥832.07m |
최근 재무 상태 업데이트
업데이트 없음
Recent updates
Shareholders Will Be Pleased With The Quality of Mega Genomics' (HKG:6667) Earnings
Oct 03
Returns On Capital Signal Tricky Times Ahead For Mega Genomics (HKG:6667)
Aug 28Some Investors May Be Worried About Mega Genomics' (HKG:6667) Returns On Capital
May 03Calculating The Intrinsic Value Of Mega Genomics Limited (HKG:6667)
Feb 20Mega Genomics Limited's (HKG:6667) Share Price Could Signal Some Risk
Aug 12A Look At The Fair Value Of Mega Genomics Limited (HKG:6667)
Nov 07재무 상태 분석
단기부채: 6667's short term assets (CN¥710.9M) exceed its short term liabilities (CN¥131.0M).
장기 부채: 6667's short term assets (CN¥710.9M) exceed its long term liabilities (CN¥38.4M).
부채 대 자본 내역 및 분석
부채 수준: 6667 has more cash than its total debt.
부채 감소: Insufficient data to determine if 6667's debt to equity ratio has reduced over the past 5 years.
부채 범위: 6667's debt is well covered by operating cash flow (513.3%).
이자 보장: 6667 earns more interest than it pays, so coverage of interest payments is not a concern.